Risk is a lens, not a leash. Once teams see what truly threatens patients and processes, the busywork falls away, and quality ...

Pearl, the global leader in AI solutions for dentistry, today announced that the U.S. Food and Drug Administration (FDA) has ...

Policymakers across Europe and the United States are moving to classify many clinical AI tools as high-risk systems, ...

For more than 15 years, Aldo Vidinha has worked at the intersection of engineering, quality, and regulatory strategy in the ...

Omedus is developing tech and medical innovations for military and health care uses. Founder and CEO Jessica Queen has ...

Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.

PointCross today announced general availability of an AI-augmented transformative single-track process for nonclinical data management. The innovation enables simultaneous generation of ...

All investors would love to get rich overnight. As anyone who's been in the market for a while can attest, however, that's ...

This detailed overview explains the technical mechanisms of LC-MS proteomics, including peptide separation, ion generation, ...

One week after its Kickstarter debut, Anycubic's Photon P1 has attracted more than 1,200 backers and raised nearly US$880,000, signaling strong early demand for a new class of desktop resin 3D ...

Regulators like the FDA are updating their rules to handle AI’s unique nature, but keeping up with rapid changes and global ...